Sizing up competitors in a rapidly moving market is never easy. From Principal Investigators, to leading companies and start-ups, our research gauges the size of market segments, and we effectively forecast new growth areas, based on M&A activity, patent filings, regulatory approvals, corporate information, grants, social media, blogs and news.
We cover the market and look at both new and exisiting products, forthcoming innovations and pipeline products. Particular focus includes:
We examine hundreds of diseases to discover unmet needs in areas of diagnosis and treatment. Using our massive platform we're able to segment patient populations, find under-performing products, reveal real-world evidence on product usage, and determine how a disease / condition of interest is currently diagnosed, and whether it is economically effective.
From where will come the next great innovation? From tracking novel biomarkers and treatments, technological enhancements, and clinical trial results, we provide clients with a unique perspective on biomedical innovation. Particular focus includes:
We use proven and scalable software to aggregate millions of unrelated information sources, and index, clean, store, and present data.
Advanced mathematics and machine learning algorithms rank and segment information, as well as evaluate documents and data in conjunction with a proprietary, hand-curated, controlled vocabulary of millions of specific biomedical terms.